PHIO PHARMACEUTICALS CORP.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q Nov 14, 2024 FORM 10-Q FOR SEPT 2024
8-K Nov 14, 2024 FORM 8-K
SC 13G/A Nov 13, 2024 AMENDMENT NO. 5 TO SCHEDULE 13G
8-K Nov 7, 2024 FORM 8-K
4 Sep 13, 2024
4 Sep 13, 2024
4 Sep 13, 2024
4 Sep 12, 2024
4 Sep 12, 2024
4 Sep 12, 2024
4 Aug 15, 2024
8-K Aug 14, 2024 CURRENT REPORT
10-Q Aug 14, 2024 FORM 10-Q FOR JUNE 2024
3 Aug 9, 2024
424B3 Aug 5, 2024 FORM 424B3
EFFECT Aug 1, 2024
8-K Aug 1, 2024 CURRENT REPORT
CORRESP Jul 30, 2024
UPLOAD Jul 29, 2024
S-1 Jul 26, 2024 REGISTRATION STATEMENT
8-K Jul 24, 2024 FORM 8-K
D Jul 24, 2024
8-K Jul 12, 2024 FORM 8-K
8-K Jul 5, 2024 FORM 8-K
8-K Jul 2, 2024 FORM 8-K
← Newer Page 6 of 36 · 883 filings Older →